新型单核Zn（Ⅱ）配合物{Zn（H2O）6·（pbsa）2·2H2O}的合成、晶体结构及其光学性质

在水中采用回流法合成了Zn(Ⅱ)单核配合物{Zn(H2O)6·(pbsa)2·2H2O(1),pbsa=2-苯基苯并咪唑-5-磺酸阴离子},其结构和性能经UV-Vis,FL,X-射线单晶衍射和TG表征。1属单斜晶系,空间群C2/m,晶胞参数a=23.223(2),b=6.905 6(5),c=11.670 1(9),β=119.660(2)°,V=1 626.3(2)3,Z=2,Dc=1.544 mg·cm-3。1的中心离子为Zn(Ⅱ),与六个水分子配位;pbsa没有与中心离子配位,只起电荷平衡作用;未配位的水分子像节点一样通过氢键将1连接成三维网状的空间结构。1的λmax位于318 nm;在430 nm波长激发下,1的最大荧光发射峰位于425 nm和465 nm。     

新型Co（Ⅲ）配合物（CoL3）的合成及其晶体结构

以3,5-二溴水杨醛缩甲胺希夫碱(HL)为定向配体,硝酸钴为金属离子源,采用溶剂热法在乙腈中合成了一个新型的单核钴(Ⅲ)配合物(Co L3,1),其结构经IR和X-射线单晶衍射表征。1属单斜晶系,空间群P21/n,晶胞参数a=13.833 2(4),b=20.558 2(8),c=20.691 7(7),β=100.622(3)°,V=5 783.6(3)3,Z=8,Dc=2.147 g·cm-3,R1=0.045,wR2=0.092,S=1.02。1中Co(Ⅲ)分别与三个二齿配体上的三个O原子和三个N原子配位,形成轻度扭曲的八面体构型。分子间通过C-H┈Br和Br┈Br弱作用相互连接成三维网络结构。     

Synthesis,Crystal Structure and MMCT Property of a New Mixed-valence Cyanide-bridged Binuclear Complex

A new mixed-valence cyanide-bridged complex, Br3Fe(μ-NC)RuBr(dppm)2(dppm = bis(diphenylphosphino)methane), was obtained through the reaction between trans-(dppm)2ClRuCN and FeBr3. Its crystal structure was characterized. Electronic absorption spectra indicate the existence of metal-to-metal charge transfer(MMCT) and this complex is Class Ⅱ mixed valence complexes according to the classification of Robin and Day. Magnetic analysis shows it is paramagnetic.     

Synthesis and Crystal Structure of（S）-N-（hexahydro-2-oxo-1H-azepin-3-yl）-3-phenyl-2-propenamide

The title compound(S)-N-(hexahydro-2-oxo-1H-azepin-3-yl)-3-phenyl-2-propenamide(C15H18N2O2, Mr = 258.31) was synthesized by the reaction of(S)-α-amino-ε-caprolactam with 3-phenyl-2- propenoyl chloride. Its chemical structure was determined by 1H NMR, 13C NMR, H RMS and X-ray single-crystal diffraction. The crystal belongs to the monoclinic system, space group P21/n with a = 14.957(3), b = 4.884(1), c = 18.630(4), β = 95.91(3)o, V = 1353.7(5)3, Z = 4, Dc = 1.267 g/cm3, μ = 0.085 mm-1, F(000) = 552, R = 0.0671 and wR = 0.1547 for 2473 observed reflections with I 2σ(I).     

Synthesis and Crystal Structure of Tianagliflozin Triacetate

The title compound tianagliflozin triacetate 1 was synthesized and its crystal structure was determined by single-crystal X-ray diffraction.The crystal belongs to monoclinic system(C27H31ClO8,Mr = 518.97),space group P21 with a = 5.3913(11),b = 16.137(2),c = 15.411(3) ,β = 94.15(3)°,V = 1337.3(5) 3,Z = 2,Dc = 1.289 g/cm3,F(000) = 548,μ = 0.190 mm-1,the final R = 0.0374 and wR = 0.0809 for 3981 observed reflections(I 2σ(I)).The structure of 1,triacetate of a highly potent SGLT2 inhibitor tianagliflozin,was unambiguously determined by single-crystal X-ray diffraction,which helped to confirm the desired β configuration at the anomeric center and the position where the deoxylation occurred.The two benzene rings in the lattice are basically orthogonal to each other.There are four intermolecular hydrogen bonds in the crystal,which helps to further stabilize the crystal.     

A New Terbium（III） Coordination Compound with 2-Thiophenecarboxylic Ligand： Synthesis and Crystal Structure①

A new coordination compound with formula [Tb（2-TC）3（DMF）]n （1, 2-TC = 2-thio- phenecarboxylic ligand and DMF = dimethylformamide） was synthesized by solvothermal method. The structure of compound 1 was determined by single-crystal X-ray diffraction analyses, and characterized by elemental analyses, IR and powder X-ray diffraction. Structure analysis reveals compound 1, exhibiting a one-dimensional chain structure, crystallizes in triclinic space group P21/c, with a = 9.2751（19）, b = 16.490（3）, c = 15.865（5） A, β = 118.98（2）°, V= 2122.7（9）A3, D,. = 1.916 g/cm3, Mr= 612.45 （C18H15NO7S3Tb）, F（000） = 1196,μ（MoKa） = 3.67 mm-1, Z = 4, R = 0.0616 and wR = 0.0962 for 3865 observed reflections （I 〉 2o（I））, and R = 0.1092 for all data. Meanwhile, the photoluminescent properties of compound 1 were also investigated in the solid state at room temperature.     

Syntheses,Characterizations, and Crystal Structures of Two Binuclear Silver Complexes Based on O,O'-Dialkyldithiophosphate and 1,10-Phenanthroline

Two binuclear silver complexes, [Ag2{μ-S2P(OCH2Ph)2}2(phen)2](1) and [Ag2{μ-S2P(OCH2CH2Ph)2}2(phen)2](2), were synthesized and characterized by elemental analysis, infrared spectrum, thermo-gravimetric analysis and X-ray single-crystal diffraction. Complex 1 crystallizes in the triclinic system, space group P1 with a = 9.7881(4), b = 10.7726(4), c = 13.1952(6) , a= 103.686(4), γ = 99.477(3), γ = 107.494(4)°, V = 1246.88(9) 3, Dc = 1.591 g·m-3 and Z = 1; Complex 2 is of monoclinic system, space group P21/n with a = 10.6014(8), b = 24.3969(15), c = 11.5353(10) , β = 14.125(10)°, V = 2722.9(4) 3, Dc = 1.526 g·m-3 and Z = 2. In the molecules of 1 and 2, O,O'-dialkyldithiophosphate anions,(PhCH2O)PS2- and(PhCH2CH2O)PS2- act as bridging ligands and connect two Ag(I) centers into a binuclear unit with Ag2S4P2 eight-membered rings in "chair" conformations. In both crystal structures, face-to-face π-π stacking interactions between the adjacent paralleling aromatic rings of 1,10-phenanthroline play a prominent role in the crystal packing and result in a 1D chain. And such 1D chains are further linked into 3D networks by weak intermolecular C–H···π interactions for 1.     

Synthesis,Crystal Structure and Anticoagulant Activity of 5-Chloro-N-[[（5S）-2-oxo-3-[4-（2- oxopyridin-1 （2H）-yl）phenyl] oxazolidin-5- yl] methyl] thiophene-2-carboxamide①

The title compound(zifaxaban 2, C20H16ClN3O4 S, Mr = 429.87) was synthesized and its crystal structure was determined by single-crystal X-ray diffraction. Zifaxaban crystallizes in monoclinic, space group P21 with a = 5.7900(12), b = 13.086(3), c = 12.889(3) A, β = 100.86(3)°, V = 959.1(3) A3, Z = 2, Dc = 1.489 g/cm3, F(000) = 444, μ = 0.342 mm-1, the final R = 0.0320 and wR = 0.0640 for 2717 observed reflections(I 2σ(I)). The absolute configuration of the stereogenic center in the title compound was confirmed to be S by single-crystal X-ray diffraction. Four existing intermolecular hydrogen bonds help to stabilize the lattice and the molecule in the lattice to adopt an L-shape conformation. Zifaxaban was slightly more active than rivaroxaban 1 in in vitro assay against human FXa and therefore is promising as a drug candidate.     

Synthesis,Crystal Structure,and Photoluminescence Properties of One Novel D-π-D Type a-Cyanostilbene Derivative

Researches on a-cyanostilbene derivatives demonstrated them to be promising AIE or AIEE structural molecules and potential photoelectric materials. One novel a-cyanostilbene derivative, namely （E）-2-（4-butoxyphenyl）-3-（4-（diethylamino）phenyl）acrylonitrile （BPDPA）, has been designed, synthesized and characterized. The crystalline structure of BPDPA has been studied in detail. The single-crystal X-ray diffraction revealed BPDPA crystallizes in triclinic space group Pi, with a = 12.860（5）, b = 13.327（5）, c = 15.016（5）А, a = 72.650（5）, β = 66.969（5）, Y = 62.897（5）°, Mr = 696.95, V= 2085.6（13） A3, Z = 2, Dc = 1.110 g/cm-3, p = 0.068 mm1, F（000） = 752, Rint = 0.0264, R（I〉 2σ（/）） = 0.0649, wR（l〉 2σ（/） = 0.1724, R（all data） = 0.1321, wR （all data） = 0.2158, completeness to theta = 25.00 is 99.4% and GOF = 1.067. Like most reported a-cyanostilbene derivatives, BPDPA possesses a somewhat twisted molecular structure. UV-Vis and FL measurements showed an obviously bathochromic effect of BPDPA with increasing the polarity of the solvents.     

A Novel 3D Heterobimetallic Cyano-bridged Coor- dination Polymer {（NH4）2[Cd（H20）Fe（CN）6]}n： Synthesis and Crystal Structure①

A novel heterobimetaUic coordination polymer, {（NH4）2[Cd（H20）Fe（CN）6]}n 1, has been synthesized by using the slow diffusion method and structurally characterized by elemental analysis, 1R spectroscopy and single-crystal X-ray diffraction. The crystal crystallizes in the monoclinic system, space group P21/n, a = 7.4202（16）, b = 14.939（3）, c = 10.868（2） A and ,8 = 91.660（3）°. For 1, five CN groups of Fe（CN）6]4- are involved in bridging. The polymer displays a 3D open microporous framework with 5-connected uninodal （46.64） topology.